Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND)
Aparicio, J., Virgili, A., Capdevila, J., Muñoz Boza, F., Álvarez, R., Bosch, C., Cámara, J., Fernandez-Martos, C., Fernandez-Plana, J., Gallego, J., Gallego, R., Hernández-Yagüe, X., Macías Declara, I., Rodríguez-Salas, N., Vera, R., Taberner, M., Maurel, J.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Pathological complete response after chemoradiotherapy in locally advanced rectal cancer: Capecitabine or 5-fluorouracil? Which is better?
Hernández-Yagüe, X., Canals-Subirats, E., Esquerda, G. Mateu, Sanz, C. Auñón, Genover, A. Maroto, Bergkvist, D. Julià, Romeu, N. Gómez, Fernández, M. Osorio, Gine, P. Planellas, Queralt, B., Farrés-Coll, R.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain
Rubió, J, Marcos-Gragera, R, Ortiz, M.R, Miró, J, Vilardell, L, Gironès, J, Hernandez-Yagüe, X, Codina-Cazador, A, Bernadó, L, Izquierdo, A, Colomer, R
Published in European journal of cancer (1990) (01.01.2007)
Published in European journal of cancer (1990) (01.01.2007)
Get full text
Journal Article
P-174 Outcomes in local gastric cancer resected without neoadjuvant therapy: A descriptive study
Buscarons, E. Bujons, Ferrer, C. Montañes, Marti, L. Llavata, Ortega, J. Sabaté, Bassols, C. Codony, Velasco, A. García, Pujadas de Palol, M., Hernández-Yagüe, X., Sanchez, R. Guardeño
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
P-237 Percentage of residual fibrosis versus Rubbia-Brandt classification as predictors of overall survival in metastatic colorectal cancer. Which is better?
Hernández-Yagüe, X., Ortiz-Duran, R., Lopez-Ben, S., Meléndez-Muñoz, C., Buxó, M., Llavata, L., Castro-Gutiérrez, E., Falgueras-Verdaguer, L., Fuertes-Negro, B., Brunet-Vidal, J., Figueras-Felip, J.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
P-252 Residual fibrosis after treatment with anti-epidermal growth factor receptor or bevacizumab in colorectal liver metastases and its correlation with survival: A retrospective pooled analysis
Hernández-Yagüe, X., Lopez-Ben, S., Llavata, L., Mateu Esquerda, G., Casellas-Robert, M., Ortiz-Duran, R., Buxó, M., Albiol-Quer, M., Meléndez-Muñoz, C., Brunet-Vidal, J., Figueras-Felip, J.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
P-118 Cetuximab rechallenge in RAS, BRAF, EGFR-ECD wild type metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies in first line: The CITRIC study
Santos Vivas, C., Salva, F., Fernández-Rodríguez, C., Alonso Orduña, V., Losa, F., Paez, D., Vidal, J., Salud, A., Ribera Fernández, P., Safont Aguilera, M., Tarazona, N., Hernández-Yagüe, X., Layos Romero, L., Garcia-Carbonero, R., Rivera, F., Álvarez Gallego, R., Bellosillo, B., Montagut, C.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
P-191Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND)
Aparicio, J, Virgili, A, Capdevila, J, Muñoz Boza, F, Álvarez, R, Bosch, C, Cámara, J, Fernandez-Martos, C, Fernandez-Plana, J, Gallego, J, Gallego, R, Hernández-Yagüe, X, Macías Declara, I, Rodríguez-Salas, N, Vera, R, Taberner, M, Maurel, J
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Retrospective analysis of pathological response in colorectal cancer liver metastases following treatment with bevacizumab
Vera, R., Gomez Dorronsoro, M., Lopez-Ben, S., Viudez, A., Queralt, B., Hernandez, I., Ortiz-Duran, M. R., Zazpe, C., Soriano, J., Amat, I., Herrera Cabezón, J., Diaz, E., Codina-Barreras, A., Hernandez-Yagüe, X., Quera, A., Figueras, J.
Published in Clinical & translational oncology (01.08.2014)
Published in Clinical & translational oncology (01.08.2014)
Get full text
Journal Article
P-302Pathological complete response after chemoradiotherapy in locally advanced rectal cancer: Capecitabine or 5-fluorouracil? Which is better?
Hernández-Yagüe, X, Canals-Subirats, E, Esquerda, G Mateu, Sanz, C Auñón, Genover, A Maroto, Bergkvist, D Julià, Romeu, N Gómez, Fernández, M Osorio, Gine, P Planellas, Queralt, B, Farrés-Coll, R
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Preoperative treatment with bevacizumab in combination with chemotherapy in patients with unresectable metastatic colorectal carcinoma
Figueras, J., Lopez-Ben, S., Alsina, M., Soriano, J., Hernandez-Yagüe, X., Albiol, M., Guardeño, R., Codina-Barreras, A., Queralt, B.
Published in Clinical & translational oncology (01.06.2013)
Published in Clinical & translational oncology (01.06.2013)
Get full text
Journal Article
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study
Sastre, J., García-Alfonso, P., Viéitez, J.M., Cano, M.T., Rivera, F., Reina-Zoilo, J.J., Salud-Salvia, A., Quintero, G., Robles-Díaz, L., Safont, M.J., La Casta, A., Gil, S., Polo, E., Asensio-Martínez, E., García-Paredes, B., López, R.L., Guillot, M., Valladares-Ayerbes, M., Aranda, E., Díaz-Rubio, E., Viéitez, J.M., Jiménez, P., Aguilar, E. Aranda, Gómez, A., Gil Calle, S., Salud, A., Valladares, M., Graña, B., García-Alfonso, P., Rivera, F., Quintero, G., Reina, J.J., González Flores, E., Salgado, M., Grande, E., Guillén, C., Garcia Carbonero, R., Flor, M.J., Safont, M.J., La Casta, A., Arévalo, S., Sastre, J., López López, R., Manzano, H., Guillot, M., Hernández Yagüe, X., Arrivi, A., Falcó, E., Gallego, J., Escudero, P., Cabezas, I., Juárez, A., Gálvez, E., Grávalos, C., Robles, L., Polo, E., Dueñas, R., Campos, J.M., Albert, A., Salinas, P., Montagut, C., Provencio, M., Ruiz Casado, A., Muñoz, J., Gil Raga, M., Chilet, M.R., González González, F.J., Massutí, B., López, A., Aparicio, J., Marín, M., Alfaro, J., Zanui, M., Gutiérrez Abad, D., García Tapiador, A.M., García-Girón, C., Molina Saera, J., Torres Sánchez, E., López, I., Bosch, C., Valero, J., Martínez de Prado, P.
Published in ESMO open (01.04.2021)
Published in ESMO open (01.04.2021)
Get full text
Journal Article
511MO Third line rechallenge with cetuximab (Cet) and irinotecan in circulating tumor DNA (ctDNA) selected metastatic colorectal cancer (mCRC) patients: The randomized phase II CITRIC trial
Vivas, C. Santos, Barrull, J. Vidal, Rodriguez, C. Fernandez, Ballabrera, F. Salvà, Alonso-Orduna, V., Garcia-Carbonero, R., Losa, F., Llavero, N. Tarazona, Aguileria, M.J. Safont, Herrero, F. Rivera, Romero, L. Layos, Morales, M.J. Ortiz, Salud, A., Alcaide-Garcia, J., Paez, D., Hernandez-Yagüe, X., Gallego, R. Alvarez, Vera, R., Paricio, B. Bellosillo, Viladot, C. Montagut
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article